| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a47c2a3f3d32fec1ac5be06ea5d93a6f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-145 |
| filingDate |
2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0abe90a476bb45533efe839de057dc15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a227cccc7f50b9a7fd4760a36939a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_403ef2bf9bebf62e032ca6274a8b7d04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1a2fa60d5d91d1caa62d9c2a5f5663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e0935d69b0971cb18cea13719ed6196 |
| publicationDate |
2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3319643-A1 |
| titleOfInvention |
Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents |
| abstract |
The present invention relates to compounds according to Formula (I) or Formula (II), which are potential bone imaging agents and therapeutic agents for treating bone tumors and metastases. Certain compounds labeled with 68 Ga displayed excellent bone uptake and retention. The present invention also relates to pharmaceutical compositions comprising a pharmaceutical acceptable carrier and a compound of Formula (I) or Formula (II) or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2015-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |